Meros Investment Management LP Purchases New Position in InfuSystem Holdings, Inc. $INFU

Meros Investment Management LP acquired a new position in InfuSystem Holdings, Inc. (NYSE:INFU) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 468,934 shares of the company’s stock, valued at approximately $4,525,213,000. Meros Investment Management LP owned 2.32% of InfuSystem as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new position in shares of InfuSystem during the second quarter valued at approximately $15,299,000. Minerva Advisors LLC lifted its stake in InfuSystem by 5.2% in the fourth quarter. Minerva Advisors LLC now owns 1,078,731 shares of the company’s stock worth $9,676,000 after acquiring an additional 52,942 shares during the period. Vanguard Group Inc. boosted its holdings in InfuSystem by 1.9% in the third quarter. Vanguard Group Inc. now owns 976,177 shares of the company’s stock valued at $10,113,000 after acquiring an additional 18,539 shares in the last quarter. Punch & Associates Investment Management Inc. increased its position in InfuSystem by 1.6% during the 1st quarter. Punch & Associates Investment Management Inc. now owns 837,925 shares of the company’s stock valued at $7,734,000 after purchasing an additional 13,175 shares during the period. Finally, Heartland Advisors Inc. purchased a new position in InfuSystem during the 2nd quarter valued at $6,755,000. 71.13% of the stock is currently owned by institutional investors.

InfuSystem Stock Up 0.6%

Shares of NYSE:INFU opened at $12.02 on Wednesday. InfuSystem Holdings, Inc. has a 52-week low of $7.29 and a 52-week high of $12.97. The firm has a market capitalization of $242.59 million, a P/E ratio of 200.37 and a beta of 1.42. The stock has a 50 day moving average price of $10.30 and a 200-day moving average price of $9.59. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98.

InfuSystem declared that its Board of Directors has initiated a stock buyback program on Tuesday, May 19th that allows the company to repurchase $20.00 million in shares. This repurchase authorization allows the company to repurchase up to 10.2% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s board of directors believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Separately, B. Riley Financial restated a “buy” rating and issued a $20.00 price objective (up from $12.00) on shares of InfuSystem in a report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $16.67.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.